Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Total Occlusions: Device Obstacle or Opportunity?

This article was originally published in Start Up

Executive Summary

The market is promising for using catheters, instead of surgery, to open vascular blockages. But the right technology remains elusive.

You may also be interested in...



Avinger: Finally, Seeing Through Total Occlusions, But Will Clinical Value Generate Economic Return?

Noted physician/entrepreneur John Simpson is back. His latest company, Avinger, has finally achieved his long-sought goal: combining imaging and therapeutics in catheter technology for crossing CTOs. Will clinical innovation be enough to reward Avinger in an increasingly economically focused medtech world?

FlowCardia: Playing it Safe in Total Occlusions

Chronic total occlusions remain one of the most significant challenges and opportunities facing interventional cardiologists and radiologists. FlowCardia is looking to succeed where other device companies have failed by emphasizing safety and simplicity.

FlowCardia: Playing it Safe in Total Occlusions

Chronic total occlusions remain one of the most significant challenges and opportunities facing interventional cardiologists and radiologists. FlowCardia is looking to succeed where other device companies have failed by emphasizing safety and simplicity.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT037318

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel